S
SubjectWell
Risk-free patient recruitment for clinical trials
About SubjectWell
SubjectWell is a startup that specializes in patient recruitment for clinical trials. The company operates in the healthcare and pharmaceutical sectors, serving clients such as pharmaceutical companies, biotech firms, and clinical research organizations. SubjectWell's primary service is to connect these clients with qualified patients who are willing to participate in clinical trials.
The company leverages real-time data to identify and refer patients who meet the specific criteria of a given study. This data-driven approach allows SubjectWell to deliver referrals at a much faster rate compared to traditional methods. Their "high touch" approach means they actively engage with patients, which results in higher randomization rates—patients who are more likely to be selected and participate in the trial.
SubjectWell's business model is performance-based, meaning clients only pay for patients who actually randomize into the clinical trial. This reduces financial risk for their clients, as they are not paying upfront for uncertain outcomes. The company offers a risk-free assessment to potential clients, using real-world data to estimate how many qualified patients they can recruit for a specific study. This customized analysis helps clients understand how quickly they can meet their enrollment goals.
In summary, SubjectWell accelerates the patient recruitment process for clinical trials, providing a cost-effective and efficient solution for their clients. By focusing on real-time data and a performance-based payment model, they minimize financial risk and maximize the likelihood of successful patient enrollment.
Source: Dealroom company dataAt a glance
- Founded
- 2012
- Headquarters
- Austin, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Healthy Ventures
Series A3 investors entered at this stage
Windham Venture Partners
Geekdom Fund
Asset Management Ventures
Series B and later1 investor entered at this stage
WindRose Health Investors
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about SubjectWell on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See SubjectWell on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.